Brief: Kintara Therapeutics Inc Gets Nasdaq Notice On Non-Compliance With $1 Minimum Bid Price Requirement
15/12/2023 22:42
Dec 15 (Reuters) - Kintara Therapeutics Inc KTRA.O :
* KINTARA THERAPEUTICS INC - ON DEC 13, GOT NOTICE FROM
NASDAQ
INDICATING THAT CO IS NOT IN COMPLIANCE WITH $1.00 MINIMUM BID
PRICE REQUIREMENT
Further company coverage: KTRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.